UK markets closed

Arrowhead Pharmaceuticals, Inc. (0HI3.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
23.71+0.59 (+2.55%)
At close: 05:22PM BST

Insider roster

Individual or entityMost-recent transactionDateShares owned as of transaction date

ANZALONE CHRISTOPHER RICHARD
Chief Executive Officer

Sale

31 Jan 2024

3,715,050

FERRARI MAURO
Director

Sale

11 Jan 2024

60,778

GIVEN DOUGLAS BRUCE
Director

Sale

11 Jan 2024

129,711

HAMILTON JAMES C
Officer

Sale

01 Apr 2024

204,851

LU HONGBO B
Director

Purchase

20 Mar 2024

33,680

MYSZKOWSKI KENNETH ALLEN
Chief Financial Officer

Sale

06 Mar 2024

400,600

O'BRIEN PATRICK C
Chief Operating Officer

Sale

05 Jan 2024

464,385

SAN MARTIN JAVIER
Officer

Sale

05 Jan 2024

198,497

VAKIENER VICTORIA
Director

Sale

11 Jan 2024

32,001

WADDILL WILLIAM D
Director

Sale

11 Jan 2024

47,870

*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.